ADMA Biologics, Inc. · 3 months ago
Director, Center Operations
ADMA Biologics, Inc. is seeking a Director of Center Operations responsible for supervising all activities within the plasma collection center. The role focuses on production, regulatory compliance, budget management, and human resources management to ensure goals are met while maintaining compliance and donor satisfaction.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Provide supervision and direction for all activities within the plasma collection center
Manage production, regulatory compliance, budget management, human resources management, and information systems management
Ensure timelines are achieved and center staff communication is effective and routine
Achieve production goals and maximize donor satisfaction in a safe, healthy, and friendly environment for both donor and staff
Act as a liaison with corporate office functions
Qualification
Required
Supervision and direction for all activities within the plasma collection center
Production management
Regulatory compliance management
Budget management
Human resources management
Information systems management
Ability to meet production goals while remaining in a state of regulatory compliance
Management and administrative planning of all Center activities
Achievement of company and regulatory objectives using standard operating procedures (SOPs)
Training and establishment of work performance objectives
Team building
Directing activities to ensure timelines are achieved
Effective and routine center staff communication
Maximizing donor satisfaction
Providing a safe, healthy, and friendly environment for both donor and staff
Acting as a liaison with corporate office functions
Company
ADMA Biologics, Inc.
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.04BKey Investors
JP MorganAres ManagementHayfin Capital Management
2025-08-06Post Ipo Debt· $300M
2023-12-18Post Ipo Debt· $135M
2022-12-07Post Ipo Equity· $60M
Recent News
MarketScreener
2026-01-05
2025-11-07
Company data provided by crunchbase